#AskBQ: Looking To Invest In Bhansali Engineering, Graphite India, Sun Pharma? Read This
#AskBQ is BloombergQuint's daily offering where market experts help investors make the right investment choice — be it in equities, commodities or the derivatives markets.
On Thursday's episode, TS Harihar, founder and chief executive at HRBV Client Solutions Pvt. Ltd. and Sumeet Bagadia, associate director at Choice Broking gave their views on Bhansali Engineering, Graphite India, Sun Pharma and many more.
Watch the show
Here are the edited excerpts of the interview.
Richa Shukla: I bought 100 shares of Jet Airways at Rs 568 with a long-term view. Should I hold or sell?
Sumeet Bagadia: I would advice you to hold.
TS Harihar: I would advise you to average at levels of Rs 490 and get an average cost at Rs 540.
Ramesh Tiwari: I bought 50 shares of Natco Pharma at Rs 700 with a two-year view. Should I hold or sell?
Sumeet Bagadia: I would advise you to hold.
TS Harihar: Same.
Shikhar Tandon: I bought 200 shares of Sun Pharma at Rs 490 with a three-year view. Should I hold or sell?
Sumeet Bagadia: I would advice you to hold.
TS Harihar: Exit at current levels. I would prefer companies like Natco Pharma, Glenmark and Aurobindo Pharma.
Aparajita Singh: I want to invest Rs 5 lakh in the market. Please advice.
Sumeet Bagadia: I would advise you to buy in sectors like housing finance, auto and metals.
TS Harihar: I would advise you to buy in sectors like defence and chemical.
Satish Awasthi: I bought 200 shares of BPCL at Rs 538 with a long-term view. Should I hold or sell?
Sumeet Bagadia: I would advice you to hold.
TS Harihar: I would not recommend you to buy more at current market price.
Ajay Dodiya: I bought 500 shares of IDFC at Rs 58 with a six-month view. Should I hold or sell?
Sumeet Bagadia: I would advice you to hold.
TS Harihar: I prefer RBL Bank and IndusInd Bank.
Chintan: I bought 1,400 shares of Aurionpro at Rs 150 with a six-month view. Should I hold or sell?
Sumeet Bagadia: I would advise you to exit the stock if there is a pullback
Aryan Rana: I bought 100 shares of Venus Remedies with a three-month view. Should I hold or sell?
Sumeet Bagadia: I would advise you to avoid.
Abhishek Agrawal: I want to invest in Graphite India with a long-term view. Please advise.
Sumeet Bagadia: I would advise you to avoid.
Raj Shah: I bought 500 shares of Bhansali Engineering at Rs 83. Should I hold or sell?
Sumeet Bagadia: I would advise you to hold with a trailing stoploss of Rs 99
Here's how you can get your queries answered:
- Tweet us your using #AskBQ
- WhatsApp us on +91-8291229686
- Call us on 022-45404141
- Email us on askbq@bloombergquint.com
Analysts' Disclosure:
TS Harihar: I personally hold stock at Natco Pharma.
Sumeet Bagadia: I have no personal holdings. Client might have position.
Disclaimer: The commentary and advice on BloombergQuint's digital and social media platforms is not a full financial plan. Investors are advised to consult a certified financial advisor/planner when making an independent decision regarding investments. No views mentioned on the programme is personal advice to anyone.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint's digital and social media platforms provide views of only SEBI registered investment advisors/analysts.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
